About BACBV
BACBV is a company based in Naarden (Netherlands) founded in 2002 was acquired by Life Technologies in January 2013. BACBV has raised $2.19 million across 3 funding rounds from investors including Life Technologies, Unilever Ventures and Fleming Family & Partners. BACBV operates in a competitive market with competitors including Purolite and Chemforase, among others.
- Headquarter Naarden, Netherlands
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.19 M (USD)
in 3 rounds
-
Latest Funding Round
$2.19 M (USD), Series A
Sep 23, 2008
-
Investors
Life Technologies
& 2 more
-
Employee Count
Not available
-
Acquired by
Life Technologies
(Jan 22, 2013)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of BACBV
BACBV has successfully raised a total of $2.19M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $2.19 million completed in September 2008. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in BACBV
BACBV has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Life Technologies, Unilever Ventures and Fleming Family & Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Corporate-backed venture capital firm focused on consumer tech and multiple sectors
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Tools and technologies for biotech and biopharma research were supplied.
|
Locked | Locked | Locked |
Investor details for BACBV
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BACBV
Investment portfolio details for BACBV
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BACBV
Detailed financials for BACBV
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bacbv Comparisons
Peer comparison for BACBV
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BACBV
BACBV operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Purolite and Chemforase, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Manufacture of resins for industrial applications
|
|
| Locked | Locked | Locked |
Affinity resins for butyrylcholinesterase purification are manufactured and sold.
|
Detailed competitors of BACBV
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bacbv
Complete news archive for BACBV
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BACBV
BACBV was founded in 2002.
BACBV is headquartered in Naarden, Netherlands. It is registered at Naarden, North Holland, Netherlands.
Amar Patel is the current CEO of BACBV.
BACBV is a funded company, having raised a total of $2.19M across 3 funding rounds to date.
Founded in 2002 in Naarden, Netherlands, BAC focuses on the biopharmaceutical sector. Separation and affinity purification products are discovered, developed, and manufactured using proprietary single-chain antibody technology known as CaptureSelect. These products support discovery, preclinical, and clinical stages in therapeutic protein production, including antibodies and fragments. Integration into Life Technologies Corporation occurred in January 2013.
BACBV's top competitors include Purolite and Chemforase.
BACBV has 3 investors. Key investors include Life Technologies, Unilever Ventures, and Fleming Family & Partners.